^ Back to Top

NEW The primary care update series is a new premium content based service from bpacnz Find out more

Report

Looking for your personalised report? Prescribers can log-in to My bpac (or create a free account) to access their individual prescribing or laboratory testing reports. Once you have logged-in, click on 'Download your reports' in your account dashboard to see your available reports.

Prescribing report: Reviewing SABA treatment for asthma management in adolescents and adults

For more than 50 years, people with asthma have been prescribed a short-acting beta2-agonist (SABA) as the first-line treatment for symptom relief. However, the accumulated weight of evidence has shifted and regular use of a SABA without concurrent inhaled corticosteroid (ICS) is no longer recommended for adolescents or adults. View Contents

National report: Reviewing SABA treatment for asthma management in adolescents and adults

For more than 50 years, people with asthma have been prescribed a short-acting beta2-agonist (SABA) as the first-line treatment for symptom relief. However, the accumulated weight of evidence has shifted and regular use of a SABA without concurrent inhaled corticosteroid (ICS) is no longer recommended for adolescents or adults. View Contents

National report: Testing for prostate cancer in primary care

This report provides an overview of laboratory prostate-specific antigen (PSA) testing in primary care to facilitate reflection, discussion and identification of opportunities to optimise patient care. View Contents

National report: The use of antipsychotic medicines in older people

The purpose of this report is to provoke thought and discussion about how and why antipsychotic medicines are prescribed to older patients. The report includes national data, and practice points for reflection. View Contents

The 2019 Annual Report is now available

The bpacnz Annual Report provides individualised and practice data on pharmaceuticals dispensed in the community for any primary care prescriber registered with us who prescribed to at least 50 patients and had more than 249 prescriptions dispensed; this includes nurse practitioners, nurse prescribers and for the first time, pharmacist prescribers. Aggregated reports are also provided for DHB and PHO facilitators.

 View Contents